Citropin 1.1 [G15P]-G, Citropin A

General Information


DRACP ID  DRACP04049

Peptide Name   Citropin 1.1 [G15P]-G, Citropin A

Sequence  GLFDVIKKVASVIGPLG

Sequence Length  17

UniProt ID  P81835 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C81H137N19O21

Absent amino acids  CEHMNQRTWY

Common amino acids  GV

Mass  199868

Pl  9.54

Basic residues  2

Acidic residues  1

Hydrophobic residues  9

Net charge  1

Boman Index  1619

Hydrophobicity  111.18

Aliphatic Index  148.82

Half Life 
  Mammalian: 20 hour
  Yeast: 30 min
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  The design and anticancer activity of a citropin11 hybrid peptide with selective activity against highly invasive metastatic cell lines

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  16496

DRACP is developed by Dr.Zheng's team.